Regency Capital Management Inc.\De Aura Biosciences, Inc. Transaction History
Regency Capital Management Inc.\De
- $164 Million
- Q1 2025
A detailed history of Regency Capital Management Inc.\De transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Regency Capital Management Inc.\De holds 749,482 shares of AURA stock, worth $4.71 Million. This represents 2.68% of its overall portfolio holdings.
Number of Shares
749,482
Previous 609,424
22.98%
Holding current value
$4.71 Million
Previous $5.01 Million
12.34%
% of portfolio
2.68%
Previous 2.93%
Shares
12 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.4MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$43.5 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$30.7 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$20.8 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$19.1 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$18.9 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $184M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...